Commerce Defines Exemptions to New 100% Pharma Import Tariff

The 100% Section 232 tariff on patented pharmaceuticals and related pharmaceutical ingredients took full effect September 29 for companies not covered under the earlier July 31 implementation date. The Commerce Department's Bureau of Industry and Security has specified which specialty pharmaceutical products qualify for a 0% tariff rate and which countries are eligible for exemptions. Drug manufacturers, importers, and distributors must now determine whether their products fall under the exempt categories or face the full tariff. The distinction affects sourcing and pricing decisions across the pharmaceutical supply chain.

Pharmacy